#METABOLOMICS WORKBENCH Lu_Group_20220325_055333 DATATRACK_ID:3139 STUDY_ID:ST002121 ANALYSIS_ID:AN003473 PROJECT_ID:PR001346
VERSION             	1
CREATED_ON             	March 25, 2022, 11:17 pm
#PROJECT
PR:PROJECT_TITLE                 	Functional metabolomics analysis of pancreatic cancer tissues with gemcitabine
PR:PROJECT_TITLE                 	treatment
PR:PROJECT_TYPE                  	Targeted MS quantitative analysis
PR:PROJECT_SUMMARY               	Characteristics of pancreatic cancer tissues metabolomics with gemcitabine
PR:PROJECT_SUMMARY               	treatment in cell derived xenograft models
PR:INSTITUTE                     	Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University
PR:DEPARTMENT                    	Shanghai Center for Systems Biomedicine
PR:LABORATORY                    	Lu Group
PR:LAST_NAME                     	Lu
PR:FIRST_NAME                    	Haitao
PR:ADDRESS                       	800 Dongchuan RD. Minhang District, Shanghai, Shanghai, 200240, China
PR:EMAIL                         	haitao_lu@sjtu.edu.cn
PR:PHONE                         	15221478139
#STUDY
ST:STUDY_TITLE                   	Functional metabolic molecule were identified as novel therapeutic targets to
ST:STUDY_TITLE                   	facilitate gemcitabine treatment against pancreatic cancer
ST:STUDY_SUMMARY                 	With the development of frontier technologies in system biology, traditional
ST:STUDY_SUMMARY                 	omics-drove phenotypic studies are insufficient to decipher the diseases.
ST:STUDY_SUMMARY                 	Therefore, for a thorough understanding of the molecular mechanisms of diseases
ST:STUDY_SUMMARY                 	to investigate novel drug targets, traditional phenotypic studies must be broken
ST:STUDY_SUMMARY                 	through to the functional exploration of molecules. Meanwhile, the intuitive
ST:STUDY_SUMMARY                 	role of small molecule compounds (metabolites) in pathogenesis, precision
ST:STUDY_SUMMARY                 	diagnosis and therapy are gradually recognized compared to macromolecules such
ST:STUDY_SUMMARY                 	as DNA, RNA and proteins. Therefore, we pioneeringly proposed Spatial Temporal
ST:STUDY_SUMMARY                 	Operative Real Metabolomics (STORM) strategy that established a relationship
ST:STUDY_SUMMARY                 	between metabolic phenotypes and functions to accurately character abnormal
ST:STUDY_SUMMARY                 	metabolisms and further identify operative functional molecules as novel
ST:STUDY_SUMMARY                 	therapeutic targets. Here, given the difficulty of pancreatic cancer (PC)
ST:STUDY_SUMMARY                 	treatment and the high resistance of clinical drugs, we were committed to
ST:STUDY_SUMMARY                 	explore new targets and drugs of pancreatic cancer from a small molecular
ST:STUDY_SUMMARY                 	functional perspective via STORM strategy. Fortunately, based on targeted
ST:STUDY_SUMMARY                 	metabolomics, we found that gemcitabine, one of the most effective clinical
ST:STUDY_SUMMARY                 	anti-PC drugs, served as a dual modulator that promote the accumulation of
ST:STUDY_SUMMARY                 	functional metabolic molecules in purine metabolism to activate down-streamed
ST:STUDY_SUMMARY                 	kinases. And the quantitative consequences of related enzymes annotated the
ST:STUDY_SUMMARY                 	unique molecular mechanisms of purine metabolism regulations by gemcitabine.
ST:STUDY_SUMMARY                 	Collectively, we broadened the cognitions of gemcitabine in tumor inhibition,
ST:STUDY_SUMMARY                 	providing potential strategies for treating PC with small molecules
ST:STUDY_SUMMARY                 	modification. Even more importantly, with the integration of multiple frontier
ST:STUDY_SUMMARY                 	technologies, the STORM strategy has proven to be well adapted to the phenotypic
ST:STUDY_SUMMARY                 	era of functional molecules devoted to innovate molecule mechanism annotation
ST:STUDY_SUMMARY                 	and therapeutic discovery.
ST:INSTITUTE                     	Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University
ST:LAST_NAME                     	Lu
ST:FIRST_NAME                    	Haitao
ST:ADDRESS                       	800 Dongchuan RD. Minhang District, Shanghai,
ST:EMAIL                         	haitao_lu@sjtu.edu.cn
ST:PHONE                         	15221478139
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	M-1	Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml mormal saline	RAW_FILE_NAME=M-1
SUBJECT_SAMPLE_FACTORS           	-	M-3	Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml mormal saline	RAW_FILE_NAME=M-3
SUBJECT_SAMPLE_FACTORS           	-	M-4	Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml mormal saline	RAW_FILE_NAME=M-4
SUBJECT_SAMPLE_FACTORS           	-	M-5	Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml mormal saline	RAW_FILE_NAME=M-5
SUBJECT_SAMPLE_FACTORS           	-	M-6	Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml mormal saline	RAW_FILE_NAME=M-6
SUBJECT_SAMPLE_FACTORS           	-	M-7	Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml mormal saline	RAW_FILE_NAME=M-7
SUBJECT_SAMPLE_FACTORS           	-	G-1	Treatment:2 times per week with 3 consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml	RAW_FILE_NAME=G-1
SUBJECT_SAMPLE_FACTORS           	-	G-2	Treatment:2 times per week with 3 consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml	RAW_FILE_NAME=G-2
SUBJECT_SAMPLE_FACTORS           	-	G-4	Treatment:2 times per week with 3 consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml	RAW_FILE_NAME=G-4
SUBJECT_SAMPLE_FACTORS           	-	G-5	Treatment:2 times per week with 3 consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml	RAW_FILE_NAME=G-5
SUBJECT_SAMPLE_FACTORS           	-	G-6	Treatment:2 times per week with 3 consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml	RAW_FILE_NAME=G-6
SUBJECT_SAMPLE_FACTORS           	-	G-7	Treatment:2 times per week with 3 consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml	RAW_FILE_NAME=G-7
#COLLECTION
CO:COLLECTION_SUMMARY            	Tumor tissues were stripped from euthanized mice for further assays
CO:SAMPLE_TYPE                   	Subcutaneous tumor tissues of pancreatic cancer
#TREATMENT
TR:TREATMENT_SUMMARY             	All mice are fed at a constant temperature of 20-26℃ with a free choice of
TR:TREATMENT_SUMMARY             	standard food and water with 12-hour light/dark cycle.After 2 weeks acclimatized
TR:TREATMENT_SUMMARY             	breeding, Aspc-1 cells were injected into right armpit of nude mice when they 8
TR:TREATMENT_SUMMARY             	weeks old. When solid tumors can be stably observed, treating mice with 25mg/kg
TR:TREATMENT_SUMMARY             	gemcitabine twice a week by intraperitoneal injection of Gem-treated group,
TR:TREATMENT_SUMMARY             	meanwhile, the control group received the same volume of saline. Measuring tumor
TR:TREATMENT_SUMMARY             	volume every two days. 21 days later, tumors were stripped and weighed, parts of
TR:TREATMENT_SUMMARY             	which were embedded in paraffin for immunohistochemistry, and the residues were
TR:TREATMENT_SUMMARY             	kept in -80 degree refrigerator.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	100-130 mg tissue samples tumor tissues have to be broken by oscillation with
SP:SAMPLEPREP_SUMMARY            	60HZ and 2 minutes in iced 80% methanol solution (mixed with internal standard
SP:SAMPLEPREP_SUMMARY            	0.001mg/ml 4-chloro-DL-phenylalanine). centrifuging at 20,000 g for 10 min at 4
SP:SAMPLEPREP_SUMMARY            	°C, and mixing the supernatants with 800 μL ice-cold acetonitrile. Then the
SP:SAMPLEPREP_SUMMARY            	supernatant obtained by centrifugation was filtered through a 0.22 µm organic
SP:SAMPLEPREP_SUMMARY            	phase membrane, blown dry in nitrogen, reconstituted in 100 µL of water and
SP:SAMPLEPREP_SUMMARY            	transferred to vials for metabolomics assay.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Agilent 1290 Infinity
CH:COLUMN_NAME                   	Waters Acquity HSS T3 column (100 mm×2.1, 1.8 μm)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Agilent 6495 QQQ
MS:INSTRUMENT_TYPE               	Triple quadrupole
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	Agilent MassHunter Workstation Data Acquisition Agilent MassHunter
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	13
MS_METABOLITE_DATA_START
Samples	M-1	M-3	M-4	M-5	M-6	M-7	G-1	G-2	G-4	G-5	G-6	G-7
Factors	Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml mormal saline	Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml mormal saline	Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml mormal saline	Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml mormal saline	Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml mormal saline	Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml mormal saline	Treatment:2 times per week with 3 consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml	Treatment:2 times per week with 3 consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml	Treatment:2 times per week with 3 consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml	Treatment:2 times per week with 3 consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml	Treatment:2 times per week with 3 consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml	Treatment:2 times per week with 3 consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml
Citrate	45172579.98	41062444.66	61394756.16	45003714.71	35228968.89	38090727.16	50774017.92	47699342.89	59684517.03	64543934.42	49528116.85	42501022.41
Taurocholic acid	19645.48376	21730.80117	12886.646	137518.0565	7149.574663	6667.871281	31354.1961	9342.97996	16558.19322	7254.299391	229875.2907	204648.5543
Cinnamoylglycine	30303.20173	27339.15502	62028.42036	38425.03348	16548.90833	26212.46056	23448.09635	39140.95513	26137.42471	42430.85438	15394.30802	57240.26246
Isocitric acid	32665618.55	38601395.89	47171450.63	34620235.97	33590105.33	38254428.26	38649213.77	30106026.86	47333753.32	46826498.89	44592182.89	33906813.05
Taurochenodeoxycholic acid	5265.52459	4895.72457	11960.95575	19372.04797	1831.421914	8263.859124	8128.820797	5741.647108	8938.733105	7067.714455	26865.27291	33887.97652
Citraconic acid	347822.5884	235341.5354	292062.8603	601573.0478	240792.7042	406274.0196	252203.1673	340120.3446	411193.1294	334125.1724	372738.385	303879.6155
Methylmalonic acid	10262175.02	12304771.87	10566728.61	9527978.565	15479423.84	13072131.55	10343217.98	11027647.65	16523961.64	12976911	16094005.42	11128933.26
3-Hydroxybenzoic acid	27636.71874	27186.96957	41239.55769	47380.66736	17564.42741	32382.61177	35769.81874	29705.29206	37677.80839	37293.44251	24847.47792	29987.27688
Uridine	3647511.293	5151176.633	2747837.169	3137497.862	3606412.076	3550243.332	3274481.58	3029662.833	5396667.477	3026953.215	3616212.682	3887594.113
L-Lactate	13430319.25	13291584.69	12080827.05	10593406.31	13897443.59	12285680.49	12416600.85	11639375.42	13513366.36	13773044.12	13373707.42	12831753.11
Oxalic acid	1929631.662	2075042.938	1855046.851	1663249.743	1962335.447	1887535.116	1800374.462	1774855.57	2153950.58	1902151.709	2023540.496	1979743.143
Malonic acid	2990925.077	2196115.487	819300.9076	2989902.914	2616162.087	3009578.096	554604.1869	1451534.782	4165497.884	2370677.724	4642656.133	1586875.397
4-Hydroxybenzoic acid	32302.09226	34064.60709	46397.07714	49653.05696	19114.42894	33753.58971	37793.73164	34588.27019	42174.69539	48219.9026	26488.98887	34958.54169
Azelaic acid	928120.875	599379.5366	897255.7432	1026170.948	486079.9367	723083.1296	755238.8513	542680.1834	500950.0973	866609.7098	822168.9801	283769.555
Maleic acid	843369.8122	725568.8775	730540.7571	476044.8251	752089.7314	894694.1559	857859.8184	1162977.578	923850.7099	1247035.129	847698.8558	1578256.603
N-Acetyl-L-tryptophan	12637.37194	10846.5588	26151.9833	8261.903403	13328.69448	8764.747042	12343.48711	13822.34458	37318.86708	33347.71032	21339.28871	18697.59019
Sebacic acid	115903.8727	75391.9655	97200.24903	143956.0855	53048.29695	82262.02195	103775.048	86282.41491	84105.29679	115567.7102	93229.97832	118330.0225
N-Acetylglutamic acid	157552.7928	103400.2267	269395.5845	62630.43931	116565.9989	104370.3221	139923.9752	147399.3324	174411.7635	341631.9781	274490.0694	132865.0132
Allantoin	26173.45168	24442.00645	41401.2416	50587.23924	21493.25741	30947.11775	22660.25814	19177.23681	28816.07689	22901.85985	17760.74241	22996.13844
dUMP	36602.89418	41296.2468	43677.29564	32824.35072	19377.01624	34322.47741	47211.32536	70281.91161	46626.90529	74559.40476	50399.00819	73438.81532
Indoxyl sulfate	216711.5429	386174.652	912610.4466	342709.1821	199493.803	416573.9966	1437799.549	1040026.035	889238.3142	970177.399	594867.4892	954022.7126
2'-Deoxyinosine	1706577.201	1610218.805	1002763.952	910480.1672	2028078.448	1776796.79	1470159.873	1489556.31	1898027.912	1255986.28	1760496.379	1285836.913
Cis-Aconitic acid	406025.2483	366621.2472	390788.0905	699300.7983	381030.848	354044.8371	491166.5654	335073.4401	623720.2539	409939.4765	409816.016	404354.693
D-Glucose 6-phosphate	876994.6114	920505.7641	587570.1181	515015.9433	1155988.626	1364810.188	1073200.778	1174495.731	1321224.188	862294.9038	1045095.14	1359042.976
Flavin adenine dinucleotide	2511513.233	2331275.424	2202276.345	1748250.814	2052786.907	2066503.748	2445232.545	2145927.788	2676720.165	2380210.519	2363701.728	2364256.717
Fumarate	843369.8122	748994.081	730540.7571	476044.8251	420448.1679	894694.1559	857859.8184	1162977.578	923850.7099	1229747.049	830777.4665	1578256.603
Malic acid	22108980.08	19328863.01	20726060.72	18614506.36	18904180.7	20960258.57	21685047.71	22488028.68	23320485.41	23345238	21663062.83	23191530.74
D-Fructose	2445575.712	3342083.218	2596066.752	1863970.718	2895747.837	2480991.012	2898635.726	2306808.227	2842074.383	2917088.777	3161895.67	2189390.102
Succinic acid	10293883.96	11039360.88	10661151.27	9108569.868	14007734.3	12099899.93	10322404.97	11043405.73	15637607.51	11794805.2	16152471.17	9709185.817
Gluconic acid	67730.10465	83469.80968	113102.9895	84095.15218	59598.30233	101128.632	86274.71298	73545.11188	131775.9376	175161.0839	94043.46465	109513.6684
Glucose	3453200.26	4056576.207	3407530.455	3101665.953	4123298.188	3841600.466	4072175.34	3374661.022	4166156.066	3757564.823	4611976.391	3531337.118
2-hydroxy-2-phenylpropanoic acid	633396.2675	476599.989	804634.4719	1105647.527	470868.6053	634929.7779	709441.2235	814818.6217	655515.834	983600.8236	564194.111	570318.7426
p-Hydroxyphenylpropionic acid	288898.4919	253652.8129	516426.0674	431988.739	120742.2804	411942.7118	228315.8946	232263.049	429908.8878	277792.666	330104.1834	364564.8206
3-Hydroxyphenylpropionic acid	633396.2675	476599.989	804634.4719	1105647.527	470868.6053	634929.7779	709441.2235	814818.6217	655515.834	983600.8236	564194.111	531550.4489
Docosahexaenoic acid	186139.8519	167942.3595	173444.2973	185820.9929	151750.9329	176675.4474	155481.8168	159615.7004	198064.4012	148035.7328	157308.8714	181711.4826
Phenyllactic acid	151466.7912	126050.0094	262114.0609	207357.7433	122072.967	96149.93788	184208.979	101854.256	86986.27215	95715.52155	105778.6531	142711.665
Citramalic acid	59105.66189	59254.12699	70884.84967	75344.01181	46744.3431	47075.89934	44151.20247	41096.20078	66919.44919	80960.68998	45835.07173	69753.51536
Glutaric acid	63142.17921	75629.6069	86429.68119	68563.98679	55387.93047	65062.23398	76791.60217	76355.69319	102432.5639	96176.66158	77918.89656	90312.66878
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	m/z	RT
Citrate	191.11	1.63
Taurocholic acid	514.28	10.94
Cinnamoylglycine	204.06	9.53
Isocitric acid	191.02	1.64
Taurochenodeoxycholic acid	498.29	12.39
Citraconic acid	129.09	1.73
Methylmalonic acid	117.02	2.11
3-Hydroxybenzoic acid	137.02	6.46
Uridine	243.1	1.88
L-Lactate	89.02	1.51
Oxalic acid	89	1.51
Malonic acid	103	2.29
4-Hydroxybenzoic acid	137.02	6.46
Azelaic acid	187.1	9.8
Maleic acid	115	1.88
N-Acetyl-L-tryptophan	245.09	9.06
Sebacic acid	201.1	11.11
N-Acetylglutamic acid	188.05	1.83
Allantoin	157.03	1.01
dUMP	307.03	1.47
Indoxyl sulfate	212	6.59
2'-Deoxyinosine	251.1	3.88
Cis-Aconitic acid	173	1.73
D-Glucose 6-phosphate	259.02	1.02
Flavin adenine dinucleotide	784.15	6.23
Fumarate	115	1.84
Malic acid	133.01	1.25
D-Fructose	179.05	1.51
Succinic acid	117.02	2.09
Gluconic acid	195.05	1
Glucose	179.05	1.51
2-hydroxy-2-phenylpropanoic acid	165.05	6.91
p-Hydroxyphenylpropionic acid	165.05	6.91
3-Hydroxyphenylpropionic acid	165.05	7.08
Docosahexaenoic acid	327.23	14.98
Phenyllactic acid	165.05	8.52
Citramalic acid	147.03	2.15
Glutaric acid	131.03	3.74
METABOLITES_END
#END